(Q42644398)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

generalized anxiety disorder

2 January 2020

main subject

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Naomi M Simon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Kathryn M Connor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Richard T LeBeau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

John J Worthington

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Wei Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jonathan R T Davidson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Mark H Pollack

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

2 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

675-681

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18246327%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00213-008-1087-x

2 January 2020

exact match

0 references

cites work

The assessment of anxiety states by rating

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1087-X

Adherence to paroxetine CR compared with paroxetine IR in a Medicare-eligible population with anxiety disorders.

21 January 2018

1 reference

12 December 2020

Generalized anxiety disorder. Longitudinal course and pharmacologic treatment.

1 reference

12 December 2020

Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure

1 reference

12 December 2020

Treatment of Generalized Anxiety Disorder: Comparison of a New Beta-Blocking Drug (CGP361 A), Low-Dose Neuroleptic (Flupenthixol), and Placebo

1 reference

12 December 2020

An open-label trial of risperidone augmentation for refractory anxiety disorders

1 reference

12 December 2020

Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder

1 reference

12 December 2020

Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy

1 reference

12 December 2020

Controlled-release paroxetine in the treatment of patients with social anxiety disorder

1 reference

12 December 2020

Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles

1 reference

12 December 2020

Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.

1 reference

12 December 2020

Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review

1 reference

12 December 2020

A rating scale for drug-induced akathisia

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.

1 reference

12 December 2020

Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.

1 reference

12 December 2020

An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.

1 reference

12 December 2020

Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study

1 reference

12 December 2020

An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms

1 reference

12 December 2020

A New Depression Scale Designed to be Sensitive to Change

1 reference

12 December 2020

Effective short-term treatment of generalized anxiety disorder with trifluoperazine.

1 reference

12 December 2020

Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication.

1 reference

12 December 2020

WCA recommendations for the long-term treatment of generalized anxiety disorder

1 reference

12 December 2020

Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study

1 reference

12 December 2020

Side effects of low dose neuroleptics and their impact on clinical outcome in generalized anxiety disorder

1 reference

12 December 2020

Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database

1 reference

12 December 2020

Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication

1 reference

12 December 2020

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

12 December 2020

Impairment and quality of life in individuals with generalized anxiety disorder

1 reference

12 December 2020

Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy

1 reference

12 December 2020

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

1 reference

12 December 2020

Adjunctive risperidone in generalized anxiety disorder: a double-blind, placebo-controlled study.

1 reference

12 December 2020

A rating scale for extrapyramidal side effects

1 reference

12 December 2020

The dose-effect relationship of 0.5, 1.0 and 1.5 mg fluspirilene on anxious patients

1 reference

12 December 2020

Paroxetine efficacy in the treatment of generalized anxiety disorder

1 reference

12 December 2020

Improving depression severity assessment—II. Content, concurrent and external validity of three observer depression scales

1 reference

12 December 2020

Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

1 reference

12 December 2020